Mihaly Hajos PharmD, PhD

Professor (Adjunct) of Comparative Medicine

Departments & Organizations

Comparative Medicine


Research Interests

systems neurophysiology; biomarkers; schizophrenia; Alzheimer's disease, Huntington's disease, neuropharmacology more...


Education

  • Ph.D., University of Goteborg,
  • Pharm.D., A. Szent-Gyorgyi Medical University,

Selected Publications

  • Scott L, Feng J, Kiss T, Needle E, Atchison K, Kawabe TT, Milici AJ, Hajós-Korcsok E, Riddell D, Hajós M. Age-dependent disruption in hippocampal theta oscillation in amyloid-ß overproducing transgenic mice. Neurobiol Aging. 2012 Jul;33(7):1481.e13-23. Javitt DC, Schoepp D, Kalivas PW, Volkow ND, Zarate C, Merchant K, Bear MF, Umbricht D, Hajos M, Potter WZ, Lee CM. Translating glutamate: from pathophysiology to treatment. Sci Transl Med. 2011 Sep 28;3(102):102mr2. Siok CJ, Cogan SM, Shifflett LB, Doran AC, Kocsis B, Hajós M. Comparative analysis of the neurophysiological profile of group II metabotropic glutamate receptor activators and diazepam: effects on hippocampal and cortical EEG patterns in rats. Neuropharmacology. 2012 Jan;62(1):226-36. Kiss T, Hoffmann WE, Hajós M. Delta oscillation and short-term plasticity in the rat medial prefrontal cortex: modelling NMDA hypofunction of schizophrenia. Int J Neuropsychopharmacol. 2011 Feb;14(1):29-42. Barry RJ, Clarke AR, Hajos M, McCarthy R, Selikowitz M, Dupuy FE. Resting-state EEG gamma activity in children with attention-deficit/hyperactivity disorder. Clin Neurophysiol. 2010 Nov;121(11):1871-7. Javitt DC, Spencer KM, Thaker GK, Winterer G, Hajós M. Neurophysiological biomarkers for drug development in schizophrenia. Nat Rev Drug Discov. 2008 Jan;7(1):68-83.

more...

collapsible-single-column-one-thumbnailphotobooksupi=14011541/WCF/News.svc/

Latest News

3

Edit Profile